Catalyst Wire Dossier Catalyst Wire Dossier

0.3% Hypromellose Eyedrops

hypromellose · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 0.3% Hypromellose Eyedrops, covering 2011-03-24 to 2011-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery [Phase 4]

See pricing